Aortic Stent Grafts Market: Current Analysis and Forecast (2025-2033)

Aortic stent graft is a kind of medical device, applied in the treatment of aortic aneurysms and dissections in the areas of the thoracic and abdominal aorta. They are made up of a stent, which is a metal mesh, to reinforce the weakened aorta and combine it with a fabric graft that prevents rupture. The stent graft is inserted in a minimally invasive endovascular procedure and is delivered through the blood vessels, mostly through the femoral artery, and placed into the diseased segment of the aorta. Once deployed, it forms an effective, stable channel for blood flow, relieving the pressure against the damaged wall of the vessel.

The Aortic Stent Grafts market is set to show a growth rate of about 6.8% during the forecast period (2025-2033F). Growth of the global aortic stent grafts market is broad-based and driven by a series of key factors. With a growing number of people suffering from aortic aneurysms, especially in the elderly and individuals with lifestyle-related risk factors such as hypertension and smoking, there has been a heavy demand for efficient treatments. With advancements in technology, minimally invasive procedures have become common, including endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), due to reduced recovery time and fewer complications. Moreover, the latest innovations, such as the creation of fenestrated and branched stent grafts, treatment options in complex cases further boost the aortic stent grafts market.

For instance, according to the Centers for Disease Control and Prevention, around 9,904 deaths are caused by aortic aneurysms or aortic dissections. These growing mortality rates are increasing the demand for the aortic stent graft market.

Based on the product category, the market is categorized into abdominal aortic stent grafts and thoracic aortic stent grafts. Out of these, the abdominal aortic stent grafts market currently holds the largest market share because of the prevalence of abdominal aortic aneurysms (AAAs), which is higher in the elderly and individuals prone to high risk. The adoption of these devices is widespread because of well-established EVAR procedures, broad clinical experience, and favorable reimbursement policies. However, the thoracic aortic stent grafts market is projected to grow at a faster rate during the forecast period due to the increasing awareness levels, advancements in the TEVAR technology, and broader indications for complex thoracic conditions.

Based on the end-user category, the market is categorized into hospitals, ambulatory surgical centers, and others. Among these, hospitals hold the largest market share. Their advanced medical infrastructure, including specialized vascular surgery units and the ability to tackle complex procedures like EVAR and TEVAR, makes them dominant. Besides, hospitals are the first choice for such interventions because they offer multidisciplinary teams that can perform the procedures efficiently. However, ambulatory surgical centers (ASCs) are expected to grow rapidly in the future. Changing dynamics towards minimally invasive procedures have created additional benefits, including lower cost, shorter recovery time, and lower infection risk, and the aforementioned two factors have made ASCs an increasingly preferred alternative to patients and healthcare providers.

For a better understanding of the adoption of aortic stent grafts, the market is analyzed based on its worldwide adoption in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and Rest of World. Among these, the North America region dominates the global aortic stent grafts market due to its advanced healthcare infrastructure, a high prevalence of aortic aneurysms among the aging population, and widespread adoption of minimally invasive procedures like EVAR and TEVAR. However, the Asia-Pacific region is expected to experience the fastest growth, due to the expanding healthcare infrastructure, increasing awareness of vascular diseases, rising disposable incomes, and a growing elderly population.

Some major players running in the market include Terumo Corporation, Medtronic, Meril Life Science, Cook Group Incorporated, Braile Biomedica, Artivion, Inc., W. L. Gore & Associates, Inc., Endologix LLC, MicroPort Scientific, and Bentley InnoMed GmbH.